Research map: Workflow and Clinical Utility of Multigene Preemptive Pharmacogenomic Testing in the Emergency Department: A Single-Center Cohort Study

Back to the article

Papers in this map

  1. Which drugs cause preventable admissions to hospital? A systematic review · Rachel L. Howard · 2006 · 637 citations · Cited by this paper
  2. Nirmatrelvir-Ritonavir Versus Short-Course Remdesivir for Mild COVID-19 in High-Risk Hospitalized Patients: A Propensity Score-Matched Study · 2026 · Related
  3. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study · Jesse Joachim Swen · 2023 · 566 citations · Cited by this paper
  4. Restriction Evaluation of Appropriate Carbapenem Therapy (REACT): A Multisite Observational Study · 2026 · Related
  5. Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers · Henry Mark Dunnenberger · 2014 · 521 citations · Cited by this paper
  6. Impact of Methicillin-Resistant Staphylococcus aureus Nasal PCR Versus Culture on Vancomycin Utilization in Pneumonia Management · 2025 · Related
  7. Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process · Kelly E. Caudle · 2014 · 451 citations · Cited by this paper
  8. Time to Vancomycin De-Escalation in Pneumonia Patients Screened for MRSA Using Culture vs PCR Testing · 2026 · Related
  9. Clinically Actionable Genotypes Among 10,000 Patients With Preemptive Pharmacogenomic Testing · SL Van Driest · 2013 · 337 citations · Cited by this paper
  10. Impact of an Interruptive Alert on the Number of Women Receiving CDC-Recommended Therapy for Trichomoniasis · 2025 · Related
  11. Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping · Jonathan S. Schildcrout · 2012 · 194 citations · Cited by this paper
  12. Evaluation of Neuropsychiatric Events in Patients Receiving Levetiracetam for Seizure Prophylaxis Following Traumatic Brain Injury · 2026 · Related
  13. Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network · William S. Bush · 2016 · 191 citations · Cited by this paper
  14. Overview of Diabetes Medications: Traditional and New-Generation Agents and Their Off-Label Use for Weight Loss · 2026 · Related
  15. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users · Catherine Chanfreau‐Coffinier · 2019 · 169 citations · Cited by this paper
  16. Emergency Drug Box Accuracy: Analysis of Manual Replenishment Errors and the Use of RFID as a Preventative Strategy · 2025 · Related
  17. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy · Diana I Brixner · 2015 · 153 citations · Cited by this paper
  18. Posterior Reversible Encephalopathy Syndrome (PRES) Associated With Lenvatinib: A Disproportionality Analysis · 2026 · Related
  19. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association · Naveen L. Pereira · 2024 · 121 citations · Cited by this paper
  20. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now · Kristin Wiisanen Weitzel · 2017 · 91 citations · Cited by this paper
  21. Precision pharmacotherapy: Integrating pharmacogenomics into clinical pharmacy practice · James Kevin Hicks · 2019 · 84 citations · Cited by this paper
  22. A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care · Santenna Chenchula · 2024 · 66 citations · Cited by this paper
  23. Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling · Robert N. Schuck · 2016 · 36 citations · Cited by this paper
  24. The impact of pharmacogenetic testing in patients exposed to polypharmacy: a scoping review · Erika L. Meaddough · 2021 · 28 citations · Cited by this paper
  25. Integrating pharmacogenetic testing into primary care · Susanne B. Haga · 2017 · 16 citations · Cited by this paper
  26. Managing Increased Accessibility to Pharmacogenomic Data · Susanne B. Haga · 2019 · 5 citations · Cited by this paper
  27. United States Emergency Department Use of Medications with Pharmacogenetic Recommendations · Alexander T. Limkakeng · 2021 · 5 citations · Cited by this paper
  28. Implementing preemptive, multigene, pharmacogenomic testing in the inpatient setting: Preliminary results from a small, rural facility · Jennifer L. Cole · 2023 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)